Earnings Update: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Just Reported And Analysts Are Trimming Their Forecasts
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) recently reported its quarterly earnings, with revenues missing analyst predictions and a larger-than-forecast statutory loss per share. Following these results, analysts have trimmed their revenue forecasts for 2026 and expect an increase in per-share losses, though the consensus price target …